Key Record Dates
ClinicalTrials.gov Identifier: | NCT05394805 |
---|---|
Brief Title: | A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD) |
First Submitted : | May 25, 2022 |
First Submitted that Met QC Criteria : | May 25, 2022 |
First Posted : | May 27, 2022 |
Last Update Submitted that Met QC Criteria : | February 27, 2023 |
Last Update Posted : | March 1, 2023 |